Unpacking the Latest Options Trading Trends in Pfizer
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a bearish sentiment towards Pfizer (NYSE:PFE), with a significant move in options trading detected by Benzinga. The analysis of options activities suggests a price target window of $22.5 to $26.0 for Pfizer. Despite this bearish outlook, Pfizer's current stock price is $27.62, indicating a neutral position between overbought and oversold territories. Analysts have set an average price target of $45.0 for Pfizer, with Cantor Fitzgerald downgrading its action to Overweight.
February 12, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pfizer has seen a bearish sentiment in options trading, with a significant volume of bearish calls. However, the stock is currently trading at $27.62, above the bearish target window of $22.5 to $26.0. Analysts have a higher price target of $45.0, indicating potential upside.
The bearish sentiment in options trading suggests a potential short-term downside risk for Pfizer. However, the current trading price above the bearish target window and the higher analyst price target of $45.0 indicate mixed signals. The neutral RSI reading further complicates the short-term outlook, leading to a neutral score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100